ATRACURIUM BESYLATE, created in 2000 (United States), from 1125 sister brands and 17478 competing brands. The ATRACURIUM BESYLATE brand is owned by Pfizer Inc, a company listed in New York. ATRACURIUM BESYLATE is part of the Drug Manufacturers activity sector.